NDC 67296-2164 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC67296-2164

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Redpharm Drug
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205601
Marketed since
April 13, 2020
Listing expires
December 31, 2026
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (2)

Package NDCDescriptionSince
67296-2164-112 TABLET in 1 BOTTLE, PLASTIC (67296-2164-1)Apr 13, 2020
67296-2164-66 TABLET in 1 BOTTLE, PLASTIC (67296-2164-6)Apr 13, 2020

Other Buprenorphine and Naloxone products